TG Therapeutics, Inc. Announces Clinical Data Presentations at the Upcoming 14th International Conference on Malignant Lymphoma
TG Therapeutics, Inc. (TGTX)
Last tg therapeutics, inc. earnings: 11/12 07:34 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.tgtherapeutics.com
Company Research
Source: GlobeNewswire
NEW YORK, June 08, 2017 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced that clinical abstracts featuring TG-1101 and TGR-1202 have been selected for presentation at the upcoming 14th International Conference on Malignant Lymphoma (ICML), to be held from June 14 - 17, 2017, in Lugano, Switzerland. The abstracts were made public yesterday, and are included in the Abstract Book available through the ICML meeting website at www.lymphcon.ch. Details of the data presentations are outlined below. Oral Presentations: Title: Updated results of a multicenter phase I/Ib study of TGR-1202 in combination with ibrutinib in patients with relapsed or refractory MCL or CLL Abstract Number: 040Presentation Date & Time: Wednesday, June 14, 2017 17:50 CESTSession Title: Chemotherapy-Free CombinationsPresenter: Matthew S. Davids, MD, Dana-Farber Cancer Institute Title: Ublituximab and ibrutinib for previously treated genetically high-risk chronic lymphocytic leukemia: Resu
Show less
Read more
Impact Snapshot
Event Time:
TGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TGTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TGTX alerts
High impacting TG Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TGTX
News
- TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Why TG Therapeutics Stock Was Rocketing Higher This Week [Yahoo! Finance]Yahoo! Finance
- TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at HC Wainwright from $45.00 to $49.00. They now have a "buy" rating on the stock.MarketBeat
- TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at LADENBURG THALM/SH SH from $39.00 to $40.00. They now have a "buy" rating on the stock.MarketBeat
- TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
TGTX
Earnings
- 5/1/24 - Miss
TGTX
Sec Filings
- 5/1/24 - Form 8-K
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- TGTX's page on the SEC website